Literature DB >> 2239903

The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.

J A Cauley1, J P Gutai, L H Kuller, J G Powell.   

Abstract

The relation of concentrations of endogenous estrogens and androgens to lipid and lipoprotein levels was examined in 176 white, postmenopausal women (mean age, 58 years) with an average of 9 years since the onset of menopause. All of the women were participants in a clinical trial of the effect of walking on postmenopausal bone loss. In that trial, women were randomized into either a walking group or a control group and were followed for 3 years. There were no differences in the serum hormones or lipids by randomized group, and hence, results from this study are presented for both groups combined. None of the women were on estrogen replacement therapy. Data were available from year 1 (1982-1983) of the trial for the estrogens, lipids, and lipoproteins. Information on androgens was available for 143 of these women. Hormone levels were determined by highly specific methods involving extraction, column chromatography, and radioimmunoassay. About 50% of the women had estradiol levels at or below the sensitivity level (2.5 pg/ml) of the assay; therefore, estradiol levels were viewed as dichotomous (measurable/not measurable), and the estradiol results should be interpreted with caution. There was little relation of the androgens to the lipid values. Univariate analyses suggested a direct relation between total cholesterol, low density lipoprotein cholesterol, and triglyceride levels with estradiol. An inverse relation was suggested between serum estrone and estradiol and total high density lipoprotein (HDL) cholesterol and HDL2 cholesterol, although none of these associations were statistically significant. Multiple regression analyses revealed that the primary determinant of the HDL cholesterol and triglyceride levels was the degree of obesity as estimated by the body mass index (weight (kg)/height (m)2). Addition of estrone or estradiol to the models did not contribute to the prediction of lipid levels. These results do not support the hypothesis of there being a relation between endogenous sex hormone levels and lipid levels in postmenopausal women. The results suggest that sex hormones cannot explain the sex difference in lipid levels and may not contribute to the rise in coronary heart disease that occurs in women around menopause.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239903     DOI: 10.1093/oxfordjournals.aje.a115731

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Lipoprotein subclasses and endogenous sex hormones in women at midlife.

Authors:  Samar R El Khoudary; Maria M Brooks; Rebecca C Thurston; Karen A Matthews
Journal:  J Lipid Res       Date:  2014-05-22       Impact factor: 5.922

Review 2.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

3.  Endogenous hormones and coronary heart disease in postmenopausal women.

Authors:  Yu Chen; Anne Zeleniuch-Jacquotte; Alan A Arslan; Oktawia Wojcik; Paolo Toniolo; Roy E Shore; Mortimer Levitz; Karen L Koenig
Journal:  Atherosclerosis       Date:  2011-03-01       Impact factor: 5.162

4.  Comparisons between Bioelectrical Impedance Variables, Functional Tests and Blood Markers Based on BMI in Older Women and Their Association with Phase Angle.

Authors:  Rafael Oliveira; César Leão; Ana Filipa Silva; Filipe Manuel Clemente; Carlos Tadeu Santamarinha; Hadi Nobari; João Paulo Brito
Journal:  Int J Environ Res Public Health       Date:  2022-06-03       Impact factor: 4.614

5.  Cardiometabolic risk profiles in pre- versus postmenopausal women with spinal cord injury:: preliminary findings.

Authors:  Hillary Hosier; Suzanne L Groah; Alex V Libin; Emily Tinsley; Patricia Burns; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

6.  Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women.

Authors:  E Barrett-Connor; D Goodman-Gruen
Journal:  BMJ       Date:  1995-11-04

7.  Debate: The potential role of estrogen in the prevention of heart disease in women after menopause.

Authors:  Rebecca R Johnson; Mary E Sweeney
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

8.  Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.

Authors:  Hong Sook Ko; Chee Jeong Kim; Wang Seong Ryu
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.